• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管性血友病的实验室诊断

Laboratory diagnosis of von Willebrand disease.

作者信息

Roberts J C, Flood V H

机构信息

Bleeding & Clotting Disorders Institute, Peoria, IL, USA.

Division of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.

出版信息

Int J Lab Hematol. 2015 May;37 Suppl 1(Suppl 1):11-7. doi: 10.1111/ijlh.12345.

DOI:10.1111/ijlh.12345
PMID:25976955
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5600156/
Abstract

Von Willebrand disease (VWD) is considered the most common inherited bleeding disorder and may also be the most difficult to diagnose. Clinical symptoms of VWD include predominantly mild mucosal bleeding; surgical bleeding may occur with specific challenges and joint bleeding can occur in the most severe forms. A family history either of diagnosed VWD or of bleeding symptoms is typically present. Laboratory diagnosis requires a series of assays of von Willebrand factor (VWF) quantity and function, and factor VIII activity, with no single straightforward diagnostic test available to either confirm or exclude the diagnosis. Newer assays of VWF function are becoming more available and useful in determining the laboratory diagnosis of VWD.

摘要

血管性血友病(VWD)被认为是最常见的遗传性出血性疾病,也可能是最难诊断的疾病。VWD的临床症状主要包括轻度黏膜出血;在特定情况下可能会出现手术出血,最严重的形式会出现关节出血。通常存在确诊VWD或出血症状的家族史。实验室诊断需要一系列检测血管性血友病因子(VWF)数量和功能以及因子VIII活性的试验,没有单一直接的诊断测试可用于确诊或排除诊断。VWF功能的新检测方法在确定VWD的实验室诊断方面越来越容易获得且有用。

相似文献

1
Laboratory diagnosis of von Willebrand disease.血管性血友病的实验室诊断
Int J Lab Hematol. 2015 May;37 Suppl 1(Suppl 1):11-7. doi: 10.1111/ijlh.12345.
2
Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.血管性血友病的诊断与分类:各种血管性血友病因子功能检测的鉴别效用综述
Blood Coagul Fibrinolysis. 2011 Oct;22(7):553-64. doi: 10.1097/MBC.0b013e32834a7e01.
3
New advances in the diagnosis of von Willebrand disease.血管性血友病的诊断新进展。
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):596-600. doi: 10.1182/hematology.2019000064.
4
von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.基于儿科人群的血管性血友病——1型诊断标准及血小板功能分析仪-100和血管性血友病因子/胶原结合试验应用的比较
Thromb Haemost. 2000 Sep;84(3):401-9.
5
Diagnosis and management of von Willebrand disease in Australia.澳大利亚的血管性血友病诊断与管理。
Semin Thromb Hemost. 2011 Jul;37(5):542-54. doi: 10.1055/s-0031-1281041. Epub 2011 Nov 18.
6
What have we learned from large population studies of von Willebrand disease?我们从血管性血友病的大规模人群研究中学到了什么?
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):670-677. doi: 10.1182/asheducation-2016.1.670.
7
Current and emerging approaches for assessing von Willebrand disease in 2016.2016年评估血管性血友病的现有方法及新出现的方法。
Int J Lab Hematol. 2016 May;38 Suppl 1:41-9. doi: 10.1111/ijlh.12540.
8
Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease.血管性血友病因子胶原结合试验在血管性血友病诊断中的应用。
Am J Hematol. 2017 Jan;92(1):114-118. doi: 10.1002/ajh.24556. Epub 2016 Oct 14.
9
Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo).血管性血友病因子瑞斯托霉素辅因子(VWF:RCo)的实验室检测
Methods Mol Biol. 2017;1646:435-451. doi: 10.1007/978-1-4939-7196-1_32.
10
High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.高分辨率多聚体分析和PFA-100血小板功能分析仪能够在血管性血友病因子辅因子活性与血管性血友病因子抗原水平无病理比值的情况下检测出2A型血管性血友病。
Clin Lab. 2012;58(11-12):1203-9.

引用本文的文献

1
Von Willebrand Factor Collagen-Binding Activity and Von Willebrand Factor-Mediated Platelet Adhesion in Patients with Coronary Artery Disease.冠心病患者血管性血友病因子胶原结合活性及血管性血友病因子介导的血小板黏附
Biomedicines. 2024 Sep 3;12(9):2007. doi: 10.3390/biomedicines12092007.
2
Epidemiological, Demographic, and Clinical Characteristics of Von Willebrand Disease Patients in Zahedan City, Iran: A Descriptive Study.伊朗扎黑丹市血管性血友病患者的流行病学、人口统计学和临床特征:一项描述性研究
Int J Hematol Oncol Stem Cell Res. 2024 Jul 1;18(3):220-226. doi: 10.18502/ijhoscr.v18i3.16102.
3
Thrombocytopenia and Bleeding in Chronic Kidney Disease: A Case of Acquired Von Willebrand Syndrome.慢性肾脏病中的血小板减少症与出血:一例获得性血管性血友病综合征病例
Cureus. 2024 Jul 31;16(7):e65834. doi: 10.7759/cureus.65834. eCollection 2024 Jul.
4
Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study.经导管主动脉瓣植入术患者瓣叶血栓形成的预测模型:EFFORT研究
Clin Res Cardiol. 2024 Jul 16. doi: 10.1007/s00392-024-02486-3.
5
Von Willebrand Factor (VWF) multiplex activity assay differentiation of type 1 von Willebrand Disease (VWD) and variant VWD.血管性血友病因子(VWF)多重活性测定对 1 型血管性血友病(VWD)和变异型 VWD 的鉴别诊断。
Haemophilia. 2024 Jan;30(1):161-168. doi: 10.1111/hae.14901. Epub 2023 Nov 27.
6
Von Willebrand Factor as a Biomarker for Liver Disease - An Update.血管性血友病因子作为肝脏疾病的生物标志物——最新进展
J Clin Exp Hepatol. 2023 Nov-Dec;13(6):1047-1060. doi: 10.1016/j.jceh.2023.05.016. Epub 2023 Jun 2.
7
Native Tricuspid Valve Infective Endocarditis After Breast Skin Abscess.乳腺皮肤脓肿后发生的原发性三尖瓣感染性心内膜炎。
Cureus. 2023 Oct 6;15(10):e46607. doi: 10.7759/cureus.46607. eCollection 2023 Oct.
8
Platelet Adhesion Mediated by von Willebrand Factor at High Shear Rates Is Associated with Premature Coronary Artery Disease.在高剪切率下由血管性血友病因子介导的血小板黏附与早发性冠状动脉疾病相关。
Biomedicines. 2023 Jul 6;11(7):1916. doi: 10.3390/biomedicines11071916.
9
Acquired Von Willebrand Factor Deficiency at Patient-Prosthesis Mismatch after AVR Procedure-A Narrative Review.人工主动脉瓣置换术后患者-假体不匹配导致获得性血管性血友病因子缺乏症:一项叙述性综述。
Medicina (Kaunas). 2023 May 16;59(5):954. doi: 10.3390/medicina59050954.
10
Nanotopography of Polystyrene/Poly(methyl methacrylate) for the Promotion of Patient Specific Von Willebrand Factor Entrapment and Platelet Adhesion in a Whole Blood Microfluidic Assay.聚苯乙烯/聚甲基丙烯酸甲酯的纳米形貌用于在全血微流控分析中促进患者特异性血管性血友病因子截留和血小板黏附
Polymers (Basel). 2023 Mar 22;15(6):1580. doi: 10.3390/polym15061580.

本文引用的文献

1
Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.迈向血管性血友病诊断的改进:几种血管性血友病因子抗原和活性自动化检测方法的比较评估
Thromb Res. 2014 Dec;134(6):1292-300. doi: 10.1016/j.thromres.2014.09.024. Epub 2014 Sep 28.
2
Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin.基于在无瑞斯托霉素情况下糖蛋白Ib结合的血管性血友病因子活性测定的性能评估及多中心研究。
Blood Coagul Fibrinolysis. 2014 Dec;25(8):860-70. doi: 10.1097/MBC.0000000000000169.
3
Common and rare von Willebrand factor (VWF) coding variants, VWF levels, and factor VIII levels in African Americans: the NHLBI Exome Sequencing Project.非裔美国人常见和罕见血管性血友病因子 (VWF) 编码变异体、VWF 水平和因子 VIII 水平:美国国立卫生研究院外显子组测序计划。
Blood. 2013 Jul 25;122(4):590-7. doi: 10.1182/blood-2013-02-485094. Epub 2013 May 20.
4
Critical von Willebrand factor A1 domain residues influence type VI collagen binding.关键的血管性血友病因子 A1 结构域残基影响与 VI 型胶原的结合。
J Thromb Haemost. 2012 Jul;10(7):1417-24. doi: 10.1111/j.1538-7836.2012.04746.x.
5
VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population.在非裔美国人中,健康对照者中发现的 VWF 突变和新的序列变异更为频繁。
Blood. 2012 Mar 1;119(9):2135-40. doi: 10.1182/blood-2011-10-384610. Epub 2011 Dec 23.
6
Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD.验证一种快速检测法(VWF-LIA)用于定量测定 1 型血管性血友病患者血管性血友病因子抗原,该法用于欧洲多中心研究 MCMDM-1VWD 中的 1 型血管性血友病诊断。
Thromb Res. 2010 Sep;126(3):227-31. doi: 10.1016/j.thromres.2010.06.013. Epub 2010 Jul 22.
7
The genetic basis of von Willebrand disease.血管性血友病的遗传学基础。
Blood Rev. 2010 May;24(3):123-34. doi: 10.1016/j.blre.2010.03.003. Epub 2010 Apr 20.
8
Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor.非裔美国人中常见的血管性血友病因子(VWF)外显子28多态性影响瑞斯托霉素辅因子对VWF活性的检测。
Blood. 2010 Jul 15;116(2):280-6. doi: 10.1182/blood-2009-10-249102. Epub 2010 Mar 15.
9
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor.W1745C和S1783A的特征:导致血管性血友病因子A3结构域中胶原蛋白结合缺陷的两个新突变。
Blood. 2009 Oct 15;114(16):3489-96. doi: 10.1182/blood-2008-10-184317. Epub 2009 Aug 17.
10
Toward a new paradigm for the identification and functional characterization of von Willebrand disease.迈向血管性血友病识别与功能特征研究的新范式。
Semin Thromb Hemost. 2009 Feb;35(1):60-75. doi: 10.1055/s-0029-1214149. Epub 2009 Mar 23.